Colorectal cancer is the 2nd deadliest cancer — yet almost entirely preventable.

The standard of care is broken.

The colonoscopy has been the gold standard for colorectal cancer screening for decades. But it's expensive, invasive, and often avoided. Patients must undergo bowel prep, sedation, and often take a full day off work. Millions simply don't get a colonoscopy and miss the 10 year window to intercept polyps before they progress to late stage malignancy.

By the time symptoms appear (rectal bleeding, sudden weight loss, unexplained pain) the disease has often progressed beyond the highly treatable window. We're diagnosing too late, it's become too costly, and comes with too much friction.

Polyp Point changes the game. A routine blood draw at an annual physical is as simple as it gets. AI analysis of a targeted biomarker panel and risk stratification results in 24–48 hours appear on our dashboard. The colonoscopy becomes the exception, not the default, and is reserved for patients who truly need it.